Short Interest in Merck KGaA (OTCMKTS:MKGAF) Grows By 27.9%

Merck KGaA (OTCMKTS:MKGAFGet Free Report) was the recipient of a large growth in short interest in the month of February. As of February 28th, there was short interest totalling 555,200 shares, a growth of 27.9% from the February 13th total of 434,000 shares. Based on an average daily trading volume, of 600 shares, the days-to-cover ratio is presently 925.3 days. Approximately 0.4% of the company’s stock are short sold.

Merck KGaA Stock Performance

Shares of Merck KGaA stock opened at $152.09 on Wednesday. The stock has a market cap of $19.66 billion, a price-to-earnings ratio of 23.22 and a beta of 0.96. The firm’s 50-day moving average is $146.57 and its 200 day moving average is $156.96. Merck KGaA has a 1 year low of $135.00 and a 1 year high of $200.56. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Featured Stories

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.